Table 2

Statistical analysis of the relationship between the expression of C2GnT mRNA and clinicopathological variables in patients expressing sialyl Lea or sialyl Lex in the pulmonary adenocarcinoma cells

No. of patients (%)
Sialyl Lea-positive group (n = 9)Sialyl Lex-positive group (n = 19)
C2GnT, positive (n = 6)C2GnT, negative (n = 3)paC2GnT, positive (n = 12)C2GnT, negative (n = 7)pa
Tumor size
 30 mm≥2 (22.2)b3 (33.3)0.16677 (36.8)3 (15.8)0.6499
 30 mm<4 (44.4)0 (0)5 (26.3)4 (21.1)
Pleural invasion
 Negative1 (11.1)2 (22.2)0.22625 (26.3)5 (26.3)0.3498
 Positive5 (55.6)1 (11.1)7 (36.8)2 (10.5)
Pulmonary metastasis
 Negative2 (22.2)3 (33.3)0.16678 (42.1)6 (31.6)0.6027
 Positive4 (44.4)0 (0)4 (21.1)1 (5.3)
Lymph node metastasis
 Negative0 (0)3 (33.3)0.0119c5 (26.3)6 (31.6)0.1473
 Positive6 (66.7)0 (0)7 (36.8)1 (5.3)
Vessel invasion
 Negative0 (0)3 (33.3)0.0119c2 (10.5)7 (36.8)0.0007c
 Positive6 (66.7)0 (0)10 (52.6)0 (0)
Lymphatic invasion
 Negative0 (0)2 (22.2)0.08335 (26.3)5 (26.3)0.3498
 Positive6 (66.7)1 (11.1)7 (36.8)2 (10.5)
  • a Analyzed by Fisher’s exact probability test.

  • b Numbers in parentheses, percentage.

  • c p < 0.05.